Date
janvier 12, 2026
Horaire
11:00 - 13:00
Lieu
Online

Introduction

This webinar is organised by the Healthcare Committee of the Saudi French Business Council (CAFS).

The topic of this webinar is:

“Digital Therapeutics: Regulatory, Reimbursement & Market Entry in Saudi & France”

Provisional program

Topic: “Digital Therapeutics: Regulatory, Reimbursement & Market Entry in Saudi & France”

  • 11 AM: Welcome & framing: Vision 2030, role of DTx in health transformation
  • 11.10 AM: French presentation: regulatory & reimbursement pathway for DTx in France (HAS, ANS, AIS)
  • 11.25 AM: Saudi perspective: regulatory / SFDA / MoH digital health / reimbursement policy
  • 11.40 AM: Case study: French DTx company entering KSA — challenges & success factors
  • 12 PM: Panel discussion: bridging evidence, pricing, localization, data requirements
  • 12.15 PM: Q&A from audience
  • 12.30 PM: Breakout (small groups) / action planning: defining a roadmap / pilot DTx entry for Saudi with French partner

Speakers

  • Dr. Nadia Cheaib, Chairwoman of ClinGroup
  • Dr. Stéphane Schuck, President of Kappa Santé
  • Mr. Ouassim Naiet El Gaied, Associate Director – Market Access at Biodimed Conseils
  • Mrs. Isabelle Zablit-Schmitz – Tuteur at the Institut National du Service Public

Organisateurs, sponsors & partenaires

Précédent SAUDI-FRENCH MEETING WITH COFACE’S GLOBAL CEO

Un grand merci à nos Membres Bienfaiteurs

Vérifié par MonsterInsights